Translational Research of Telecare for the Treatment of Hepatitis C

Table 2

Effectiveness in both groups.

	Group 1; (𝑛=150)	Group 2; (𝑛=148)
Mean post-Tx AST (U/liter)	59.7	62.1
Mean post-Tx ALT (U/liter)	51.3	56.2
Mean post-Tx HCV RNA; (number of copies/mL * 10^−6)	0.19	0.23
Number of patients with SVR (%)	99 (66)	102 (68.9)
Cost (USD)	232,632	112,500